Published in Cancer Weekly, February 28th, 2006
According to the report from the United States, "Immune-based strategies for treating and preventing cancer are increasingly being tested and include cancer vaccination, adoptive T cell therapy, and cytokine therapy. An important component of testing and development of immune-based strategies is monitoring the immunologic response."
Keith L. Knutson and collaborators at the Mayo Clinic in Rochester and University of Washington in Seattle wrote, "The ability to monitor T cell immunity has been suboptimal. The measurement of tumor-specific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.